Šalis: Australija
kalba: anglų
Šaltinis: Department of Health (Therapeutic Goods Administration)
Factor VIII, Quantity: 1000 IU; Von willebrand factor, Quantity: 2000 IU
CSL Behring Australia Pty Ltd
Injection, diluent for
Excipient Ingredients: water for injections
Intravenous
Biostate is indicated for: - the treatment and prophylaxis of haemorrhage or surgical bleeding in VWD when desmopressin (DDAVP) treatment alone is ineffective or contraindicated. - the treatment and prophylaxis of bleeding associated with FVIII deficiency due to haemophilia A.
Visual Identification: Clear, colourless solution, free from visible particles; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Listed (Export Only)
2022-06-08